Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara Czerska

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Evidence-Based Medicine|October 7, 2008
HF patients with preserved or reduced ejection fractions did not differ for survival or CV mortality at 5 yearsBarbara Czerska
Postgraduate Medicine|December 9, 2017
Congestive heart failureRobert E Hobbs, Barbara Czerska
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|March 11, 2005
Nesiritide for secondary pulmonary hypertension in patients with end-stage heart failureKate M O'Dell, James S Kalus, Suzan Kucukarslan, et al.
Pacing and Clinical Electrophysiology : PACE|May 5, 2005
Mechanism of atrial flutter occurring late after orthotopic heart transplantation with atrio-atrial anastomosisJoseph E Marine, Claudio D Schuger, Frank Bogun, et al.
The International Journal of Cardiovascular Imaging|November 20, 2010
Safety of adenosine pharmacologic stress myocardial perfusion imaging in orthotopic cardiac transplant recipients: a single center experience of 102 transplant patientsMouaz H Al-Mallah, Muhammad Arida, Enrique Garcia-Sayan, et al.
Journal of Translational Medicine|July 31, 2009
Short term effects of milrinone on biomarkers of necrosis, apoptosis, and inflammation in patients with severe heart failureDavid E Lanfear, Reema Hasan, Ramesh C Gupta, et al.
Journal of Cardiac Failure|November 13, 2007
Rationale, design, and methods for a pivotal randomized clinical trial of continuous aortic flow augmentation in patients with exacerbation of heart failure: the MOMENTUM trialBarry Greenberg, Barbara Czerska, William T Abraham, et al.
Circulation|September 4, 2008
Effects of continuous aortic flow augmentation in patients with exacerbation of heart failure inadequately responsive to medical therapy: results of the Multicenter Trial of the Orqis Medical Cancion System for the Enhanced Treatment of Heart Failure Unresponsive to Medical Therapy (MOMENTUM)Barry Greenberg, Barbara Czerska, Reynolds M Delgado, et al.
Circulation|November 9, 2005
Continuous aortic flow augmentation: a pilot study of hemodynamic and renal responses to a novel percutaneous intervention in decompensated heart failureMarvin A Konstam, Barbara Czerska, Michael Böhm, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Evidence-Based Medicine|October 7, 2008
HF patients with preserved or reduced ejection fractions did not differ for survival or CV mortality at 5 yearsBarbara Czerska
Postgraduate Medicine|December 9, 2017
Congestive heart failureRobert E Hobbs, Barbara Czerska
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|March 11, 2005
Nesiritide for secondary pulmonary hypertension in patients with end-stage heart failureKate M O'Dell, James S Kalus, Suzan Kucukarslan, et al.
Pacing and Clinical Electrophysiology : PACE|May 5, 2005
Mechanism of atrial flutter occurring late after orthotopic heart transplantation with atrio-atrial anastomosisJoseph E Marine, Claudio D Schuger, Frank Bogun, et al.
The International Journal of Cardiovascular Imaging|November 20, 2010
Safety of adenosine pharmacologic stress myocardial perfusion imaging in orthotopic cardiac transplant recipients: a single center experience of 102 transplant patientsMouaz H Al-Mallah, Muhammad Arida, Enrique Garcia-Sayan, et al.
Journal of Translational Medicine|July 31, 2009
Short term effects of milrinone on biomarkers of necrosis, apoptosis, and inflammation in patients with severe heart failureDavid E Lanfear, Reema Hasan, Ramesh C Gupta, et al.
Journal of Cardiac Failure|November 13, 2007
Rationale, design, and methods for a pivotal randomized clinical trial of continuous aortic flow augmentation in patients with exacerbation of heart failure: the MOMENTUM trialBarry Greenberg, Barbara Czerska, William T Abraham, et al.
Circulation|September 4, 2008
Effects of continuous aortic flow augmentation in patients with exacerbation of heart failure inadequately responsive to medical therapy: results of the Multicenter Trial of the Orqis Medical Cancion System for the Enhanced Treatment of Heart Failure Unresponsive to Medical Therapy (MOMENTUM)Barry Greenberg, Barbara Czerska, Reynolds M Delgado, et al.
Circulation|November 9, 2005
Continuous aortic flow augmentation: a pilot study of hemodynamic and renal responses to a novel percutaneous intervention in decompensated heart failureMarvin A Konstam, Barbara Czerska, Michael Böhm, et al.
Pageof 1